Default

Allergy and immunology

Anaesthesia

Basic research

Cardiovascular medicine

Complementary medicine and alternative therapies

Critical care / intensive care

Dentistry / oral medicine

Dermatology

Emergency medicine

Endocrinology

Epidemiology

Ethics

Evidence-based medicine

Gastroenterology

Genetics

Geriatric medicine / aging

Haematology / blood transfusion

Health economics

Health policy

History of medicine

Infectious diseases

Internal medicine

Laboratory medicine

Medical education

Medical informatics

Neurology

Nursing

Nutrition and metabolism

Obstetrics and gynaecology

Occupational and environmental medicine

Oncology

Ophthalmology

Organisation of health care

Otolaryngology / head and neck surgery

Paediatrics

Palliative care

Pathology

Patient-physician relationship

Pharmacology and therapeutics

Primary care, family medicine

Psychiatry and psychotherapy

Psychosomatics

Public health

Quality of care

Radiology

Rehabilitation medicine

Renal medicine

Respiratory medicine

Rheumatology

Sexual medicine

Sports medicine

Statistics and research methods

Surgery

Transplantation

Travel medicine

Urology

Ops! No article found. Reset filter

Prevalence of diabetes mellitus in the greater Bern region (Bern-Mittelland) 2010–2014

Original article
Reichenbach N, Laimer M, Diem P
Swiss Med Wkly. 2021;151:w20478

Administratively collected data in clinics and insurance companies constitute a convenient data source for epidemiological studies. In conjunction with the capture-recapture method an approach with comparatively low effort and costs for the surveillance of chronic disease can be provided.

Trends of incidence, mortality and survival for chronic lymphocytic leukaemia / small lymphocytic lymphoma in Switzerland between 1997 and 2016: a population-based study

Original article
Andres M, Feller A, Arndt V, The NICER Working Group
Swiss Med Wkly. 2021;151:w20463

During the last 20 years, treatment for chronic lymphocytic leukaemia and small lymphocytic lymphoma has advanced, with improved clinical outcomes in randomised controlled trials, but no data have been published from Switzerland to assess effectiveness of recent healthcare advances in CLL/SLL on a population-based level.

Prevalence of vitamin D deficiency in an inpatient population in the Swiss Canton of Basel-Country

Original article
Benhamou J, Schindler C, Rutishauser J
Swiss Med Wkly. 2021;151:w20470

Vitamin D deficiency was a common finding in this cohort, affecting all age groups and occurring in over half of the values measured. As current guidelines recommend vitamin D concentrations >75 nmol/l, only 22.1% of measured values indicated adequate vitamin D levels. This issue should be addressed in order to improve quality of life and reduce medical costs.

Hepatitis C virus elimination in Swiss opioid agonist therapy programmes – the SAMMSU cohort

Original article
Bregenzer A, Bruggmann P, Castro E, Moriggia A, Rothen M, Thurnheer MC, Vernazza P, Scheidegger C
Swiss Med Wkly. 2021;151:w20460

With nearly 100% direct-acting antiviral treatment success and a low reinfection rate, treatment uptake directly translates into a reduction of HCV-RNA prevalence. Eighty percent treatment uptake is feasible in opioid agonist therapy patients, and adherence and treatment success are not worse than in other populations.  

Harnessing unique experiences to build competence: Medical student engagement in frontline care during the COVID-19 pandemic

Viewpoint
Klasen JM, Bingisser R, Meienberg A, Bogie B
Swiss Med Wkly. 2021;151:w20480

As countries experience subsequent pandemic waves and identified variants of SARS-CoV-2, the lessons learned from the current interventions may help guide medical education leaders across the globe in their decisions concerning how to promote medical student engagement in frontline care during a continuing public health crisis.

Cohort profile: SARS-CoV-2/COVID-19 hospitalised patients in Switzerland

Original article
Thiabaud A, Iten A, Balmelli C, Senn L, Troillet N, Widmer A, Flury D, Schreiber PW, Vázquez M, Damonti L, Buettcher M, Vuichard-Gysin D, Kuhm C, Cusini A, Riedel T, Nussbaumer-Ochsner Y, Gaudenz R, Heininger U, Berger C, Zucol F, Bernhard-Stirnemann S, Corti N, Zimmermann P, Uka A, Niederer-Loher A, Gardiol C, Roelens M, Keiser O
Swiss Med Wkly. 2021;151:w20475

In cooperation with the Federal Office of Public Health, a surveillance database was set up in February 2020 to monitor hospitalised patients with COVID-19, in addition to their mandatory reporting system. The surveillance system has been successfully initiated and provides a robust set of data for Switzerland by including about 80% (compared with official statistics) of SARS-CoV-2/COVID-19 hospitalised patients, with similar age and comorbidity distributions. It adds detailed information on the epidemiology, risk factors and clinical course of these cases and, therefore, is a valuable addition to the existing mandatory reporting.

COVID-19 Inmate Risk Appraisal (CIRA): development and validation of a screening tool to assess COVID-19 vulnerability in prisons

Original article
Gonçalves LC, Baggio S, Weber M, Gétaz L, Wolff H, Singh J, Naegeli A, Rossegger A, Endrass J
Swiss Med Wkly. 2021;151:w20471

Although medical doctors make evaluations of COVID-19 mortality risk in certain custodial settings, there is no available tool to quantify prisoners’ vulnerability and classify them into risk categories. To address this gap and assist custodial staff taking early measures to protect detained persons, the present study collected data from the two largest prisons in Switzerland to develop a screening tool to identify prisoners at increased mortality risk and to classify them in risk categories and to test its validity when compared with national recommendations and clinical evaluation of COVID-19 vulnerability.

Swiss family physicians and home visits: a 10-year retrospective analysis and typology based on billing data

Original article
Lutula J, Taffé P, David S, Senn N, Mueller Y
Swiss Med Wkly. 2021;151:w20396

In the context of an aging population, homecare visits by family physicians may contribute to maintaining older patients at home; however, home visits by family physicians have decreased in number in the last decade with the emergence of homecare-oriented healthcare services. The authors aimed to describe the diversity of activities and evolution over time of home visits by Swiss family physicians. From 2006 to 2015, Vaud family physicians made 451,634 home visits. Most home visits were routine visits while emergency home visits were rare.

Distribution of low quality filtering facepiece respirators during the COVID-19 pandemic: an independent analysis of the situation in Switzerland

Original article
Delaloye JR, Vernez D, Suarez G, de Courten D, Zingg W, Perret V, Metzger CMJA, Richner G
Swiss Med Wkly. 2021;151:w20459

The demand for FFP respirators exceeded the supply capacity from established suppliers of the Swiss market. New production and import channels emerged, as did the number of poor-quality FFP respirators. FFP respirators remaining in stocks should be checked for conformity before being used, or eliminated and replaced if quality does not meet standards.

Retrospective analysis of adverse drug reactions leading to short-term emergency hospital readmission

Original article
Banholzer S, Dunkelmann L, Haschke M, Derungs A, Exadaktylos A, Krähenbühl S, Liakoni E
Swiss Med Wkly. 2021;151:w20400

ADR-related readmissions constituted a considerable part of short-term emergency readmissions. Despite being a relevant cause for rehospitalisation, only a minority of the ADRs were reported to the regulatory authorities. 

Verpassen Sie keinen Artikel!

close